Vitiligo

Latest News

Intralesional Methotrexate Safe, Efficacious in Localized Vitiligo Lesions
Intralesional Methotrexate Safe, Efficacious in Localized Vitiligo Lesions

June 7th 2023

More research is needed to specify long-term efficacy of the treatment and its ideal dose.

Advancing Medical Treatments for Vitiligo With Amit Pandya, MD, FAAD
Advancing Medical Treatments for Vitiligo With Amit Pandya, MD, FAAD

May 15th 2023

Iltefat Hamzavi, MD, Reviews Surgical Treatment Advances for Vitiligo
Iltefat Hamzavi, MD, Reviews Surgical Treatment Advances for Vitiligo

May 9th 2023

Examining Comorbidities in Vitiligo
Examining Comorbidities in Vitiligo

May 8th 2023

Vitamin D Lower, Basophil and Eosinophil Counts Average in Vitiligo Patients
Vitamin D Lower, Basophil and Eosinophil Counts Average in Vitiligo Patients

May 8th 2023

Latest CME Events & Activities

Burst CME: Improving Outcomes for Your Patient with Vitiligo

View More

Burst CME: Improving Outcomes for Your Patient with Vitiligo

View More

Individualizing Treatment in Moderate-to-Severe Atopic Dermatitis through Improved Clinician-Patient Communication

View More

Individualizing Treatment in Moderate-to-Severe Atopic Dermatitis through Improved Clinician-Patient Communication

View More

Individualizing Treatment in Moderate-to-Severe Atopic Dermatitis through Improved Clinician-Patient Communication

View More

Individualizing Treatment in Moderate-to-Severe Atopic Dermatitis through Improved Clinician-Patient Communication

View More

An Animated View of Alopecia Areata to Advance Our Approaches to Patient Management

View More

An Animated View of Alopecia Areata to Advance Our Approaches to Patient Management

View More

Advances in™ Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Available and Emerging Treatments

View More

Advances in™ Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Available and Emerging Treatments

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

Best Practice in the Multidisciplinary Care of the Patient with HS

View More

Addressing Challenges in the Management of HS in Special Populations

View More

Best Practice in the Multidisciplinary Care of the Patient with HS

View More

Addressing Challenges in the Management of HS in Special Populations

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Cases and Conversations™: Enhancing Diagnosis and Evaluation of Generalized Pustular Psoriasis in Advanced Practice Settings

View More

Cases and Conversations™: Enhancing Diagnosis and Evaluation of Generalized Pustular Psoriasis in Advanced Practice Settings

View More

Community Practice Connections™: Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

Community Practice Connections™: Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

Community Practice Connections™: Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

Facing the Changing Landscape for Neuromodulators and Dermal Fillers

View More

Facing the Changing Landscape for Neuromodulators and Dermal Fillers

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

More News

© 2023 MJH Life Sciences

All rights reserved.